Usana Health Sciences
USNA
191 hedge funds and large institutions have $1.08B invested in Usana Health Sciences in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 36 increasing their positions, 90 reducing their positions, and 19 closing their positions.
58% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 19
9% more capital invested
Capital invested by funds: $994M → $1.08B (+$85.6M)
6% more funds holding
Funds holding: 180 → 191 (+11)
0.95% more ownership
Funds ownership: 53.91% → 54.86% (+0.95%)
60% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 90
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $486K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pzena Investment Management
New York
|
+$34.9M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$6.1M |
| 3 |
Goldman Sachs
New York
|
+$4.89M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$4.07M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$2.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$7.87M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$7.71M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$7.38M |
| 4 |
Renaissance Technologies
New York
|
-$6.24M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.49M |
USNA Hedge Fund Activity: Q4 2021 in Review
191 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2021, worth a combined $1.08B — up 8.6% from $994M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new USNA positions and 19 closed out — a net gain of 11 holders — while 36 added to existing stakes and 90 trimmed.
The largest buyer was Pzena Investment Management, adding an estimated $34.9M. The largest seller was Man Group, cutting an estimated $7.87M.
- 191 institutional investors held Usana Health Sciences (USNA) as of Q4 2021, up from 180 in Q3 2021.
- Funds reported $1.08B of Usana Health Sciences stock for Q4 2021, up 8.6% quarter-over-quarter.
- 30 funds opened new Usana Health Sciences positions in Q4 2021 and 19 closed out, a net change of +11 holders.
- The largest Usana Health Sciences buyer in Q4 2021 was Pzena Investment Management, an estimated $34.9M added.
- The largest Usana Health Sciences seller in Q4 2021 was Man Group, an estimated $7.87M sold.
Based on aggregated 13F filings for Q4 2021.